Endocrine Abstracts

Contents

• Prize Lectures and Biographical Notes
• • The European Journal of Endocrinology Prize Lecture
  • • Sex, electrons and the adrenal - why endocrinology excites

      ea0020eje1
    • European Journal of Endocrinology Prize Winner

      ea0020eje1biog
  • The Geoffrey Harris Prize Lecture
  • • The new biology of estrogen signaling

      ea0020gh1
    • Geoffrey Harris Prize Winner

      ea0020gh1biog
• Plenary Lectures
• • Epigenetics and early environmental exposure
  • • Early influences on epigenetic regulation: relevance to chronic disease

      ea0020pl1
  • Current and novel treatment targets for bone diseases
  • • Current and novel treatment targets for bone diseases

      ea0020pl2
  • Stress and the brain: from adaptation to disease
  • • Stress and the brain: from adaptation to disease

      ea0020pl3
  • Genetics of diabetes and obesity
  • • New insight in the genetics of type 2 diabetes and obesity from genome wide associations studies

      ea0020pl4
  • New therapies for diabetes – genetically engineering tissues to maintain glucose homeostasis
  • • New therapies for diabetes - genetically engineering tissues to maintain glucose homeostasis

      ea0020pl5
  • Thyroid hormone transporters
  • • Thyroid hormone transporters

      ea0020pl6
  • Implications of adrenal hormone pulsatility
  • • Implications of adrenal hormone pulsatility

      ea0020pl7
  • 11β HSDs-common lessons from rare mutations
  • • 11[beta]-hydroxysteroid dehydrogenases: common lessons from rare mutations

      ea0020pl8
• Symposia
• • PCOS
  • • Obesity, type 2 diabetes and PCOS: a common origin?

      ea0020s1.1
    • Targeting insulin sensitivity in the treatment of PCOS

      ea0020s1.2
    • The role of HPA axis in metabolic derangements in PCOS

      ea0020s1.3
    • Treatment of infertility in women with PCOS

      ea0020s1.4
  • β cell proliferation, survival and secretion
  • • Cell-cell communication and the regulation of insulin secretion

      ea0020s2.1
    • Inflammation, cytokines and diabetes

      ea0020s2.2
    • Endoplasma reticulum stress and beta-cell apoptosis

      ea0020s2.3
    • Incretin receptor signalling, [beta]-cell proliferation and survival

      ea0020s2.4
  • Genetics in neuroendocrinology
  • • Familial hypopituitarism

      ea0020s3.1
    • ACTH insensitivity syndromes

      ea0020s3.2
    • The GPR54 gene mutations as a cause for hypogonadotropic hypogonadism

      ea0020s3.3
    • Reversible hypogonadotropic hypogonadism

      ea0020s3.4
  • Gonadal steroid replacement
  • • Testosterone and the metabolic syndrome

      ea0020s4.1
    • Pharmacogenetics of androgen action

      ea0020s4.2
    • Androgen replacement in women

      ea0020s4.3
    • Diagnosis and treatment of estrogen deficiency in men

      ea0020s4.4
  • IGF1 survival, proliferation and cancer
  • • IGF1, proliferation and cancer

      ea0020s5.1
    • IGF, somatotropic plasticity and mammalian lifespan

      ea0020s5.2
    • Nutrition, physical activity and cancer risks: the role of insulin and insulin-like growth factor-1

      ea0020s5.3
    • IGF-I and neuroprotection

      ea0020s5.4
  • Epigenetics and endocrine programing
  • • Glucocorticoids and developmental programming

      ea0020s6.1
    • Abstract unavailable

      ea0020s6.2
    • Programming of the stress system by the maternal care in animal models

      ea0020s6.3
    • Epigenetic programming and chronic physical aggression

      ea0020s6.4
  • Glucocorticoid action in the brain
  • • Glucocorticoid control of chromatin remodelling in stress-related learning and memory

      ea0020s7.1
    • Abstract unavailable

      ea0020s7.2
    • Genomic versus nongenomic corticosteroid effects

      ea0020s7.3
    • Acute and chronic stress: central and peripheral actions of glucocorticoids and insulin

      ea0020s7.4
  • Pituitary cell biology
  • • Imaging pituitary cell networks and function

      ea0020s8.1
    • New regulatory mechanisms controlling pituitary hormone secretion

      ea0020s8.2
    • New regulators of pituitary cell proliferation

      ea0020s8.3
    • Dual function of dopamine/somatostatin hybrid agonists

      ea0020s8.4
  • Addison's disease from genetics to clinical outcome
  • • Addison's disease: natural history and long-term outcome

      ea0020s9.1
    • Genetics of autoimmune Addison's disease

      ea0020s9.2
    • Early subclinical Addison's disease

      ea0020s9.3
    • New ways of delivering glucocorticoids

      ea0020s9.4
  • Secondary osteoporosis
  • • Growth hormone deficiency: bone matters

      ea0020s10.1
    • Glucocorticoid effects on bone

      ea0020s10.2
    • Defining the target level for vitamin D

      ea0020s10.3
    • Sex steroids in the regulation of bone metabolism in men

      ea0020s10.4
  • New aproaches to epigenetics and hormone/gene regulation
  • • Abstract unavailable

      ea0020s11.1
    • Existence of a 'dormant' androgen receptor-regulated gene program revealed by ChIP-seq and its influence in prostate cancer progression

      ea0020s11.2
    • MicroRNA and glucocorticoid signaling

      ea0020s11.3
  • Growth factors and signaling networks in pituitary tumours
  • • New mechanisms involved in pathogenesis of prolactinomas: critical role of the HMGA genes

      ea0020s12.1
    • MAPK and PI3K/AKT pathways in pituitary tumorigenesis

      ea0020s12.2
    • Molecular and histological prognostic markers in pituitary tumors

      ea0020s12.3
    • Predictive markers of pituitary adenoma behaviour

      ea0020s12.4
  • Pro & con – Surgery for ‘asymptomatic’ hyperparathyroidism
  • • Surgery for asymptomatic primary hyperparathyroidism

      ea0020s13.1
    • Management of mild primary hyperparathyroidism

      ea0020s13.2
  • Thyroid
  • • TSH receptor and thyroid diseases

      ea0020s14.1
    • DUOX2 gene and thyroid disease

      ea0020s14.2
    • Molecular basis of non thyroidal illness syndrome

      ea0020s14.3
    • Type 3 deiodinase and cancer

      ea0020s14.4
  • Progress in understanding and management of diabetes
  • • The metabolic syndrome is getting nervous

      ea0020s15.1
    • The metabolic memory

      ea0020s15.2
    • Role of the fatty liver (NAFLD) in the pathogenesis and treatment of Type II Diabetes

      ea0020s15.3
    • Insulin analogues in type 2 diabetes: how far have we come?

      ea0020s15.4
  • Neuroendocrine tumors
  • • Novel approaches in the treatment of NET

      ea0020s16.1
    • Moleculargenetics of neuroendocrine tumours

      ea0020s16.2
    • Peptide receptor radiotherapy for NET

      ea0020s16.3
    • PET based somatostatin receptor imaging of NET

      ea0020s16.4
  • Stem cells niches in the endocrine system
  • • Stem cell biology: lessons to learn from the fly

      ea0020s17.1
    • A population of progenitor/stem cells in the adult pituitary

      ea0020s17.2
    • Thyroid: stem cells: normal development and tumorigenesis

      ea0020s17.3
  • Should adrenal venous sampling should be performed before adrenalectomy in primary aldosteronism?
  • • Adrenal venous sampling should be performed before adrenalectomy in primary aldosteronism?

      ea0020s18.1
    • Should adrenal venous sampling be performed before adrenalectomy in primary aldosteronism? Con

      ea0020s18.2
  • Bone endocrinology
  • • Endocrine regulation of energy metabolism by the skeleton

      ea0020s19.1
    • Neuronal regulation of bone remodeling

      ea0020s19.2
    • Role of oxidative stress in skeletal involution

      ea0020s19.3
    • Lipoprotein involvement in bone metabolism

      ea0020s19.4
  • Thyroid cancer
  • • C Cell neoplasia

      ea0020s20.1
    • Ultrasound diagnosis and follow-up of thyroid cancer

      ea0020s20.2
    • Advances in management of thyroid cancer with novel chemotherapy agents

      ea0020s20.3
    • Pregnancy after exposure to radioiodine

      ea0020s20.4
  • Current problems in the management of pituitary tumours
  • • Cardiovascular morbidity and mortality in patients treated for craniopharyngioma

      ea0020s21.1
    • Factors associated with hypothalamic morbidity in patients with craniopharyngiomas

      ea0020s21.2
    • Treatment and prognosis of non-functioning pituitary adenomas

      ea0020s21.3
    • Treatment options for aggressive pituitary tumors

      ea0020s21.4
  • Tumorigenesis in pheochromocytoma/paraganliomas
  • • The Warburg effect in pheochromocytoma: a link between genetic disorders and cell metabolism

      ea0020s22.1
    • Hypoxia-induced angiogenesis in pheochromocytoma

      ea0020s22.2
    • Antiangiogenic medication in malignant pheochromocytoma

      ea0020s22.3
    • Clinical, biochemical and genetic aspects of malignant pheochromocytoma

      ea0020s22.4
  • Adrenocortical tumours – pathogenesis and management
  • • Molecular pathogenesis of adrenocortical tumors

      ea0020s23.1
    • Aberrant receptors (AR) in adrenal Cushing's syndrome

      ea0020s23.2
    • Prognostic factors and adjuvant mitotane therapy for ACC

      ea0020s23.3
    • Chemotherapy and radiotherapy for adrenocortical carcinoma (ACC)

      ea0020s23.4
  • Environmental pollutants as endocrine disruptors
  • • Environmental chemical and thyroid signalling

      ea0020s24.1
    • Molecular mechanisms of AhR and NR crosstalk

      ea0020s24.2
    • Endocrine disruptors or goitrogens? Effects of UV screens, synthetic and nutritive compounds on thyroid function

      ea0020s24.3
    • Amphibians as sensors of endocrine disruptors

      ea0020s24.4
  • Pathophysiology and treatment of Type 2 Diabetes
  • • Abstract unavailable

      ea0020s25.1
    • Monogenic obesity

      ea0020s25.2
    • FTO and obesity

      ea0020s25.3
    • Incretin-based therapies

      ea0020s25.4
  • Thyroid, Pregnancy and Fertility
  • • Thyroid disorders, infertility and miscarriages

      ea0020s26.1
    • Thyroid dysfunction during pregnancy

      ea0020s26.2
    • Postpartum thyroiditis

      ea0020s26.3
    • Consensus guidelines for the management of thyroid disorders associated with the pregnancy: an overview

      ea0020s26.4
  • Impact of SNPs on Hormone Function
  • • Pitfalls and chances of association studies

      ea0020s27.1
    • Impact of SNP on hormone function: FSH receptor

      ea0020s27.2
    • Estrogen and androgen receptor variants

      ea0020s27.3
    • LH receptor variance

      ea0020s27.4
  • Receptor Modulators
  • • Diverse actions of the nuclear receptor corepressor RIP140 in metabolic regulation

      ea0020s28.1
    • Glucocorticoid receptor ligands, dissociating between transrepression and transactivation

      ea0020s28.2
    • Selective androgen receptor modulators: mechanisms and therapeutic potential

      ea0020s28.3
    • Thyroid hormone signaling during brain development: genetic dissection in mouse

      ea0020s28.4
• Meet the Expert Sessions
• • (1)
  • • How to optimize the management of thyroid associated orbitopathy

      ea0020me1
    • Laproscopic and cortical sparing surgery in adrenal tumors

      ea0020me2
    • Clinical: adolescent and adulthood gynecomastia

      ea0020me3
    • Treatment of osteoporosis

      ea0020me4
    • Thyroid dysfunction induced by Amiodarone (focused on prevalence, predisposing factors, treatment)

      ea0020me5
    • Growth in childhood and adolescence as function of hormonal activity and nutrition

      ea0020me6
    • Menopausal hormone therapy and cardiovascular disease: the women's health initiative (WHI) randomized placebo-controlled hormone trials

      ea0020me7
    • Cushing's syndrome: pitfalls in diagnosis and management

      ea0020me8
    • New drugs in the management of the obese patients

      ea0020me9
    • Nonclassical congenital adrenal hyperplasia (CAH)

      ea0020me10
    • The relative value of 25(OH)D and 1,25(OH)2D measurements

      ea0020me11
    • Primary aldosteronism

      ea0020me12
    • New pharmaceutical contraceptive approaches

      ea0020me13
    • Molecular biology for clinicians

      ea0020me14
    • Diagnosis and treatment of type 2 diabetes mellitus in childhood

      ea0020me15
    • Abstract unavailable

      ea0020me16
• Clinical Highlights
• • Hot topics: Clinical
  • • Reduction in incidence of Type 2 diabetes by lifestyle modification in a Middle Eastern urban population: Tehran Lipid and Glucose Study

      ea0020htc1
    • Primary hyperparathyroidism (Nationwide cohort study): an increased risk of cancer and decreased survival

      ea0020htc2
    • Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival

      ea0020htc3
    • Functional analyses of four novel ret germline mutations: juxtamembrane mutations display the highest level of autophosphorylation

      ea0020htc4
    • Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomant

      ea0020htc5
• Basic Highlights
• • Hot topics: Basic
  • • Characterization of a mouse model with mutagenesis induced hyperaldosteronism

      ea0020htb1
    • Characterization of human adult stem cell populations isolated from subcutaneous and visceral adipose tissue

      ea0020htb2
    • Functional relevance of MC3R and GHSR heterodimerization in hypothalamic weight regulation

      ea0020htb3
    • Mice deficient for the Sam68 RNA binding protein are protected from dietary obesity and insulin resistance

      ea0020htb4
    • Mutations in a novel exon of the LH receptor gene cause male pseudohermaprhoditism

      ea0020htb5
• Debate
• • What to do next when Metformin does not work in Type 2 Diabetes?
  • • What to do next when metformin does not work in diabetes Type2? add SU

      ea0020d1.1
    • Add insulin

      ea0020d1.2
    • What to do next when metformin does not work in diabetes Type 2? add incretin

      ea0020d1.3
• Oral Communications
• • Endocrine Tumours
  • • Optimizing time of prophylactic surgery in ret gene carriers on the basis of serum calcitonin

      ea0020oc1.1
    • Long-term outcome of laparoscopic versus open adrenalectomy for adrenocortical carcinoma

      ea0020oc1.2
    • 131I-Iodometomidate radiotherapy for metastatic adrenocortical carcinoma: first clinical experience

      ea0020oc1.3
    • MicroRNA expression profiling and target prediction in adrenocortical tumors

      ea0020oc1.4
    • Bone morphogenetic protein 2 and 5 are down-regulated in adrenocortical carcinoma and modulate adrenal cell proliferation and steroidogenesis

      ea0020oc1.5
    • Implication of the Wnt/[beta]-catenin signaling pathway activation in the adenoma and in the malignant adrenocortical cancer

      ea0020oc1.6
  • Diabetes & Obesity
  • • A novel gene therapy strategy involving immune-modulation relinquished lymphocyte infiltration into islet grafted sites in STZ-induced diabetic rats

      ea0020oc2.1
    • Thymocyte migration is impaired in NOD mice: combined role of extracellular matrix and chemokines

      ea0020oc2.2
    • Central ghrelin administration reduces starvation-induced inflammation in rats

      ea0020oc2.3
    • Mc2 receptor in adipocytes is significant for lipid composition and regular lipolysis

      ea0020oc2.4
    • Regular aerobic activity attenuates caspase-3 activity, oxidative stress, and progression of diabetic nephropathy in db/db mice, independent of hyperglycemia

      ea0020oc2.5
  • Reproduction/Stress/Endocrine Disruptors
  • • Gapapentin for the treatment of hot flushes in women with natural or tamoxifen-induced menopause: a systematic review and a meta-analysis

      ea0020oc3.1
    • Variants in the ACVR1 gene are associated with AMH levels in women with polycystic ovary syndrome

      ea0020oc3.2
    • Variable phenotype of PROKR2 and PROK2 mutations in central hypogonadism

      ea0020oc3.3
    • Reference ranges for sex hormone-binding globulin and free testosterone index in adult men

      ea0020oc3.4
    • The xenoestrogen bisphenol A inhibits postembryonic vertebrate development by antagonizing gene regulation by thyroid hormone

      ea0020oc3.5
    • Cortisol as a prognostic marker of outcome in acute ischemic cerebrovascular events

      ea0020oc3.6
  • Acromegaly/IGF1/Type 2 Diabetes
  • • High-dose octreotide LAR in patients with acromegaly inadequately controlled by conventional somatostatin analogue therapy: a randomized, controlled trial

      ea0020oc4.1
    • Both insulin resistance and insulin secretion are involved in the pre-diabetes of acromegaly

      ea0020oc4.2
    • Homologous and heterologous in vitro regulation of pituitary receptors for somatostatin (SST), growth hormone (GH)-releasing hormone (GHRH) and ghrelin in a non-human primate (Papio anubis)

      ea0020oc4.3
    • Development of a novel anti-IGF1 receptor immunoliposomal cancer therapy with enhanced therapeutic efficiency

      ea0020oc4.4
    • Regulation of obestatin levels during unacylated ghrelin infusions in normal and type 2 diabetic patients

      ea0020oc4.5
    • Cardiovascular effects of chronic Sildenafil treatment in men with type 2 diabetes

      ea0020oc4.6
  • Thyroid: Basic and Clinical
  • • Neurological and behavioral phenotypes in mice lacking Mct8-mediated neuronal T3 uptake

      ea0020oc5.1
    • Selenium and iodine determination from single murine thyroid lobes by TXRF-spectroscopy

      ea0020oc5.2
    • The role of N-linked oligosaccharides on the function of thyrotropin: development of new agonists and antagonists

      ea0020oc5.3
    • Selenium supplementation fails to improve thyroid hormone metabolism in subjects with SBP2 gene mutations

      ea0020oc5.4
    • Graves patients with high sCTLA-4 level are at risk of severe ophthalmopathy

      ea0020oc5.5
  • Paediatric Endocrinology/Bone
  • • Pseudohypoparathyroidism type Ia and GNAS epigenetic defects: clinical evaluation and molecular analysis in 40 patients with Albright's hereditary osteodystrophy

      ea0020oc6.1
    • Recent decline in age at breast development and prolongation of puberty duration in girls

      ea0020oc6.2
    • Ghrelin and obestatin levels in normal weighted and obese prepubertal children

      ea0020oc6.3
    • Appearance matters: the impact of perceived altered appearance as a result of Klinefelter's syndrome on psycho-social functioning

      ea0020oc6.4
    • Cortical bone size is associated with serum sex hormone-binding globulin levels in healthy men at the age of peak bone mass

      ea0020oc6.5
    • Reduced selenoprotein P expression affects bone formation

      ea0020oc6.6
• Poster Presentations
• • Adrenal
  • • Hematoma: unusual presentation of adrenal masses

      ea0020p1
    • Von-Hippel Lindau disease and pheochromocytoma - case report

      ea0020p2
    • Effect of dietary protein on post-prandial salivary cortisol and androgen levels in healthy women volunteers

      ea0020p3
    • Correlation between development of testicular adrenal rest tumors and genotype in children, adolescents and adult males with congenital adrenal hyperplasia

      ea0020p4
    • Abstract unavailable

      ea0020p5
    • Unbiased stereological study of silymarin effects on adrenocortical structure of dexamethasone treated hamsters

      ea0020p6
    • Use of diurnal rhythm in salivary aldosterone to discriminate between bilateral adrenal hyperplasia and aldosterone producing adenoma

      ea0020p7
    • Effect of universal somatostatin analog (SOM230) on primary adrenal cell cultures

      ea0020p8
    • Replicating the normal cortisol circadian rhythm using a formulation of modified-release hydrocortisone

      ea0020p9
    • The cortisone to cortisol conversion in autoimmune Type 1 diabetes

      ea0020p10
    • Are there some alterations of salivary cortisol dynamics in obese patients?

      ea0020p11
    • Short term regulation of aldosterone secretion after stimulation and suppression experiments in mice

      ea0020p12
    • Autoimmune adrenal insufficiency: Addison's disease versus idiopathic isolated secondary adrenal insufficiency

      ea0020p13
    • Prediction of metabolic syndrome by low serum testosterone levels in men: results from the Study of Health in Pomerania

      ea0020p14
    • Prediction of fatal stroke by high serum aldosterone levels

      ea0020p15
    • Effects of castration and testosterone treatment on adrenal activity of a saharan gerbil, Meriones libycus in breeding and non breeding season

      ea0020p16
    • Gitelman syndrome: clinical presentation and genetic analysis of 27 patients with hypokalemia caused by renal potassium wasting

      ea0020p17
    • Bilateral adrenal incidentalomas - a clinical study of 1710 patients observed at a single endocrinological centre

      ea0020p18
    • Adipokine levels in patients with adrenal incidentaloma

      ea0020p19
    • Chemokine receptor expression in the adrenal cortex and in adrenocortical tumours

      ea0020p20
    • Bilateral macronodular adrenal hyperplasia versus bilateral micronodular adrenal hyperplasia

      ea0020p21
    • Role of chemokines MIP1[alpha] and MIP1[beta] in patients with Addison's disease isolated or associated to autoimmune thyroid disease

      ea0020p22
    • IL-6 and osteoprotogerin levels in subjects with non-functioning adrenal adenomas

      ea0020p23
    • Characterization of tyrosine hydroxylase expression in various adrenal tumors to confirm the diagnosis of adrenal pheochromocytomas

      ea0020p24
    • Towards an aldosterone producing cell line from an aldosterone producing adenoma

      ea0020p25
    • Cardiac structure and function in patients with adrenal incidentaloma: an echocardiographic study

      ea0020p26
    • Autoantibody screening of autoimmune gastrointestinal disorders in patients with autoimmune Addison disease

      ea0020p27
    • Prior dexamethasone suppression test predicts development of adrenal insufficiency after a 14 days' course of oral prednisone in healthy male volunteers

      ea0020p28
    • Glucocorticoid replacement therapy in adrenocortical insufficiency

      ea0020p29
    • Study of hormonal activity and insulin resistance in patients harbouring incidentally discovered bilateral adrenal adenomas

      ea0020p30
    • Confounding variables for plasma metanephrines and normetanephrines may influence the diagnosis of pheochromocytomas

      ea0020p31
    • Is adrenal adenoma associated with the development of non-alcoholic fatty liver disease?

      ea0020p32
    • A multi-institutional audit of laparoscopic adrenalectomy in Greece and the UK

      ea0020p33
    • The utility of the low dose dexamethasone suppression test in patients diagnosed with an adrenal incidentaloma

      ea0020p34
    • Synacten test in patients with adrenal incidentaloma

      ea0020p35
    • Central ghrelin modulates morphology and function of adrenal cortex in male rats

      ea0020p36
    • Pheochromocytoma: a retrospective study on clinical presentation, management and outcomes

      ea0020p37
    • Epidemiological study of adrenal mass in our clinical centre

      ea0020p38
    • Anemia in male patients with cushing's syndrome before and after cure

      ea0020p39
    • Bilateral adrenal hemangioma cavernosum: NMI and a CT scanning as a complementary methods in newly detected degeneration in one gland

      ea0020p40
    • Prospective evaluation of metabolic and anthropometric parameters in non-functioning adrenal adenomas

      ea0020p41
    • Metastases of renal cell carcinoma to the adrenal glands: results of surgical treatment

      ea0020p42
    • Iatrogenic Cushing's syndrome induced by topical corticoid application in child and adult

      ea0020p43
    • A rare cause of hyponatraemia presenting as acute adrenal insufficiency: bilateral adrenal haemorrhage

      ea0020p44
    • Long-term follow-up of a 46XX patient with congenital lipoid adrenal hyperplasia due to a new mutation of the steroidogenic acute regulatory protein gene

      ea0020p45
    • Insulin hypoglycemia test in the diagnosis of subclinical Cushing's syndrome

      ea0020p46
    • Carotid intima media thickness is increased and associated with morning cortisol in subjects with non-functioning adrenal incidentaloma

      ea0020p47
    • Cannabinoids and regulation of adipogenesis in differentiating 3t3-l1 preadipocytes

      ea0020p48
    • Laparoscopic resection of a large adrenal oncocytoma

      ea0020p49
    • Effects of corticosterone intake as stress-alternative hormone on broiler chickens: performance and blood parameters

      ea0020p50
    • Evaluation of cardiovascular risk factors in patients with incidentally discovered adrenal adenoma during a follow-up longer than five years

      ea0020p51
    • Expression of mTOR pathway in human adrenocortical carcinomas and in vitro effects of mTOR inhibitors in human adrenocortical cell lines

      ea0020p52
    • Prospective evaluation of tumour size and hormone secretion in adrenal incidentalomas

      ea0020p53
    • Rosiglitazone interferes with human adrenocortical carcinoma growth in a xenograft mouse model

      ea0020p54
  • Thyroid
  • • Report of twelve cases with thyroid hemiagenesis: single centre experience from Turkey

      ea0020p55
    • Severe obesity accompanied with subclinical hypothyroidism

      ea0020p56
    • The psychovegetative status at patients with postoperative primary hypothyriodism, compensated by levothyroxyn

      ea0020p57
    • The influence of thyroxine replacement therapy on bone mineral density in hypothyroid subjects

      ea0020p58
    • Real-time elastography and contrast-enhanced ultrasound for the assessment of thyroid nodules

      ea0020p59
    • The value of TSH-assisted 18F-FDG PET in initial stage M0 thyroid carcinoma with suspicion of residual or recurrent disease

      ea0020p60
    • Influence of pentoxifylline on peripheral blood mononuclear cells proliferation and apoptosis in Graves' ophthalmopathy

      ea0020p61
    • Soluble CD40 and its ligand CD154 in patients with Graves' orbitopathy during combined therapy with corticosteroids and teleradiotherapy

      ea0020p62
    • Analysis of the genetic markers: ANLN, BIRC5, UBE2C, IRAK1, ZMYCD11, CENPA in needle aspiration cytology (FNA) of thyroid and their used as targets for molecular-diagnosis and prognostic value

      ea0020p63
    • Association of G1201/T exon8 and A2257/C exon 12 polymorphisms with anti-TPO titter

      ea0020p64
    • Prevalence of growth hormone deficiency in autoimmune hypothyroidism

      ea0020p65
    • Differences in expression pattern of all-trans retinoic acid and retinoid X nuclear receptor subtypes in papillary thyroid carcinoma: a comparison with anaplastic thyroid carcinoma

      ea0020p66
    • Rapid preparation of patients with hyperthyroidism for thyroidectomy

      ea0020p67
    • Treatment of patients with Graves' orbitopathy (GO) with rituximab: effects on humoral immunity

      ea0020p68
    • Diagnostic ability of computed tomography to assess Graves ophthalmopathy

      ea0020p69
    • Recombinant-human TSH (rhTSH) testing in patients with history of thyroid microcarcinomas

      ea0020p70
    • Comparison of the analgesic efficacy of lidocaine/prilocaine (EMLA) cream and needle-free delivery of lidocaine during the fine-needle aspiration biopsy of thyroid nodules

      ea0020p71
    • The role of anti-DNA antibodies in pathogenesis of Hashimoto's thyroiditis

      ea0020p72
    • Effects of 900 MHz electromagnetic fields emitted from cellular phone on T3, T4 and cortisol hormones of Syrian Hamsters (Mesocricetus auratus)

      ea0020p73
    • The effect of overt and subclinical hypothyroidism on the development of nondipper blood pressure pattern

      ea0020p74
    • Influence of thiamazole, lithium carbonate or prednisone administration on the efficacy of radioiodine treatment (131I) in hyperthyroid patients

      ea0020p75
    • BRAFV600E mutation and timp-1 hyper-expression in classical variants of papillary thyroid carcinoma (PTC)

      ea0020p76
    • Analysis of sonic hedgehog gene in patients with thyroid hemiagenesis: preliminary report

      ea0020p77
    • Value of ultrasound elastography of the thyroid gland in differentiating malignant nodules

      ea0020p78
    • Autoimmune thyroiditis: ultrasound phenotypes in 1500 patients

      ea0020p79
    • Association between BMI and serum TSH in euthyroid subjects: the Tehran thyroid study

      ea0020p80
    • Peroxisome proliferator-activated receptor-[gamma] (PPAR[gamma]) expression in parathyroid adenomas in primary hyperparathyroidism

      ea0020p81
    • Somatostatin receptor 2 expression in cold thyroid nodules exceeds that of hot thyroid nodules, papillary thyroid carcinoma and Graves' disease

      ea0020p82
    • The role of repeat fine-needle aspiration biopsy (FNAB) in the management of thyroid nodule

      ea0020p83
    • Clinicopathologic features of incidental and nonincidental papillary thyroid microcarcinoma

      ea0020p84
    • Is there any beneficial effect of L-thyroxine replacement theraphy on cardiovascular risk factors in patients with subclinical hypothyroidism?

      ea0020p85
    • A comprehensive surgical approach of persistent cervical papillary thyroid carcinoma based on initial surgery and modern preoperative imaging modalities

      ea0020p86
    • Long-term exogenous subclinical hyperthyroidism is not associated with decrased bone mineral density in men with differentiated thyroid carcinoma

      ea0020p87
    • What is the outcome of combined therapies in amiodarone-induced thyrotoxicosis?

      ea0020p88
    • Our experience in visualization of non-radioiodine-avid differentiated thyroid carcinoma (NRADTC)

      ea0020p89
    • Long-term follow-up of antithyroid peroxidase antibodies in patients with Hashimoto's thyroiditis

      ea0020p90
    • Evaluation of chronic urticaria in patients with autoimmune thyroid disease

      ea0020p91
    • Autoimmune thyroiditis, Graves' disease and cardiovascular risk factors

      ea0020p92
    • Current iodine status in Turkey

      ea0020p93
    • Results of the 2007 follow-up monitoring survey for iodine status in Turkey

      ea0020p94
    • Evaluation of metabolic and endocrine complications in [beta]-Thalassemia major: cross sectional study of 65 patients

      ea0020p95
    • When antithyroid drugs must be started in patients with hyperemesis gravidarum?

      ea0020p96
    • Frequency of metabolic syndrome in hypothyroid patients

      ea0020p97
    • Lipid oxidation, antioxidants and paraoxonase enzyme activity in subclinical thyrotoxicosis

      ea0020p98
    • The prevalence and the significance of nodular thyroid disease (NTD) in thyroid autoimmune disease (TAD)

      ea0020p99
    • Correlation of sonographic findings with thyroid function and autoimmune activity in patients with vitiligo

      ea0020p100
    • Thyroid node pathology: correlation between cytology, histology and radiology using a new cytological classification

      ea0020p101
    • Levothyroxine suppression treatment for benign thyroid nodules alters coagulation

      ea0020p102
    • The role of large-neddle biopsy (LNB) in thyroid nodules: validation with surgical results in more than 100 cases

      ea0020p103
    • Ca 19-9 levels in Hashimoto's thyroiditis

      ea0020p104
    • No associaton of CTLA-4 gene polymorphism with Graves' disease in Turkish population

      ea0020p105
    • The ratio of malignancy in patients who underwent thyroidectomy due to follicular lesion/neoplasia

      ea0020p106
    • Concomitant thyroid carcinoma and Hashimoto thyroiditis: effect of thyroiditis on ultrasonographic and histopathologic features of nodules

      ea0020p107
    • Quality of life changes, clinical outcomes and radiation protection issues in thyroid cancer patients undergoing radioiodine remnant ablation with recombinant human thyrotropin: a randomized controlled study

      ea0020p108
    • Incidental and nonincidental papillary thyroid microcarcinomas in the material of Endocrinology Clinic and Institute of Pathology, Targu Mures

      ea0020p109
    • Erythrocyte membrane cholesterol concentration in patients with hyperthyroidism

      ea0020p110
    • Association of thyroid function tests with thyroid malignancy

      ea0020p111
    • Preoperative thyroid problems in a cardiovascular hospital

      ea0020p112
    • The changes of the IL-2,IL-4,IL-12, TNF-[alpha] and IFN-[gamma] levels with L-thyroxine treatment in patients with Hashimoto's throiditis

      ea0020p113
    • Analysis of demographic and clinical factors, affecting the outcome of radioiodine therapy in patients with hyperthyroidism

      ea0020p114
    • Thyroid function and volume disorders correlates with IQ in mental retard children (interim report)

      ea0020p115
    • Application of flow cytometry for evaluation of the phenotype of lymphocytes, present in the thyroid glands of patients with lymphoma in extrathyroid localisation

      ea0020p116
    • Subjective and objective sleep evaluation in patients with hypo- and hyper-thyroidism

      ea0020p117
    • Demographic, clinical, laboratory, ultrasonographic and cytological features of patients with Hashimoto's thyroiditis: results of a university hospital of 769 patients in Turkey

      ea0020p118
    • Assessment of the thyroid hormone's profile during pregnancy

      ea0020p119
    • Seasonal occurrence of Graves' disease and associated orbitopathy at diagnosis

      ea0020p120
    • The incidence of thyroid cancer in the North-Eastern Region of Poland: a twelve year follow-up

      ea0020p121
    • The TSH receptor antibody levels (TSHRAb) and thyroid function after 131I therapy in patients with Graves' disease - 10 years follow-up

      ea0020p122
    • The outcome of radioiodine therapy in Graves' hyperthyroidism: thyroid size as prognostic factor

      ea0020p123
    • Prognostic role of sub-clinical hypothyroidism in chronic heart failure outpatients

      ea0020p124
    • Cognitive functions and concentrations of thyroid hormones and thyrotropin in hyperthyroidism in the course of Graves' disease

      ea0020p125
    • Antitumor effects of aminobisphosphonates on anaplastic thyroid carcinoma cell lines

      ea0020p126
    • Chronic autoimmune thyroiditis morpho-functional and immunological aspects

      ea0020p127
    • Coexistence of hyperparathyroidism and non-medullary thyroid carcinoma

      ea0020p128
    • The effect of radioiodine therapy in patients with non-toxic goitre

      ea0020p129
    • A case of complete deficiency of total thyroxine-binding globulin (TBG) associated with Graves' disease

      ea0020p130
    • Regression of pulmonary arterial hypertension after treatment of hyperthyroidism

      ea0020p131
    • Thyroid function, serum lipids and insulin resistance in patients with autoimmune thyroiditis

      ea0020p132
    • Association of HTLV-I with autoimmune thyroiditis in patients with myelopathy/tropical spastic paraparesis and in HTLV-I carriers in Mashhad, North East of Iran

      ea0020p133
    • Influence of thyrometabolic state on distribution of subpopulations and fenotypes of dendritic cells in peripheral blood of the patients with chronic thyroiditis and patients monitored because of differentiated thyroid cancer

      ea0020p134
    • Evaluation of cyclins a and b1 expression in classical and nonclassical variants of papillary thyroid carcinoma

      ea0020p135
    • Alterations in TSH and thyroid hormones following mobile phone use

      ea0020p136
    • Prevalence of thyroid dysfunction in the elderly women of Iran

      ea0020p137
    • Experimental method of post-surgery hypothyroidism treatment

      ea0020p138
    • Physical and psychological well-being in adults with thyroid abnormalities

      ea0020p139
    • Anemia frequency and etiology in primary hypothyroidism

      ea0020p140
    • Thyrotropin suppression by metformin in a cohort of patients with differentiated thyroid cancer in follow-up

      ea0020p141
    • Human thyroid tissue HCO3--ATPase in norm and pathology

      ea0020p142
    • Clinical and epidemiological characteristics of thyroid hemiagenesis: ultrasound screening in patients with thyroid disease and normal population

      ea0020p143
    • Targeted high-risk case finding of thyroid dysfunction in an Iranian pregnant population

      ea0020p144
    • Assessment of biochemical parameters during Levothyroxine replacement therapy in hypothyroid patients

      ea0020p145
    • Nondiagnostic fine needle aspiration biopsy results

      ea0020p146
    • Concurrency of primary hyperparathyroidism and thyroid diseases

      ea0020p147
    • Incidental thyroid carcinoma in patients with thyrotoxicosis

      ea0020p148
    • The influence of radioiodine therapy on some parameters of oxidant/antioxidant balance in patients with toxic nodular goitre

      ea0020p149
    • Fever in the debute of the diffuse toxic goiter

      ea0020p150
    • Efficacy RAI in patients with Graves disease using different methods calculation of optimum therapeutic activity I131

      ea0020p151
    • Comparing the Outcome of radioactive iodine treatment for hyperthyroidism in a Jordanian and British cohorts

      ea0020p152
    • Primary hyperparathyroidism and synchronous thyroid disorders: a single center experience

      ea0020p153
    • Primary thyroid lymphomas

      ea0020p154
    • Iodine metabolism in hyperthyroidism

      ea0020p155
    • Analysis of ghrelin and obestatin levels in children with thyroid disease

      ea0020p156
    • Bronchiectasis as a false-positive on Iodine-131 scintigraphy in thyroid papillary carcinoma- three case reports

      ea0020p157
    • Combined doxorubicin and hyperfracionated radiation therapy of anaplastic thyroid carcinoma: case report

      ea0020p158
    • Three cases with thyroid lymphoma

      ea0020p159
    • Autoimmune thyroid disease functional evolution: the role of thyroid volume

      ea0020p160
    • Predictors of incidental parathyroidectomy during thyroid surgery

      ea0020p161
    • Thyroid surgery with the new harmonic scalpel: a prospective randomized study

      ea0020p162
    • Hashimoto's thyroiditis: the value of antithyreoperoxidase antibodies measurement

      ea0020p163
    • Propylthiouracil-induced anti-neutrophil cytoplasmic antibodies positive vasculitis

      ea0020p164
    • New clinical feature in hypothyroidism: paroxysmal supraventricular tachycardia: case report

      ea0020p165
    • Frequency of subclinical hypothyroidism (SH) and autoimmune thyroiditis (AT) in pregnancy

      ea0020p166
    • Evaluation of thyroid disorders in patients with alopecia areata

      ea0020p167
    • Unsual onset of subacute thyroiditis

      ea0020p168
    • Frequency of thyroid function test abnormalities in an open population in Queretaro, Mexico

      ea0020p169
    • Primary cavernous hemangioma of the thyroid gland

      ea0020p170
    • Heart ischemic disease patients with mild thyroid failure

      ea0020p171
  • Endocrine tumours and neoplasia
  • • Manifestations of Hyperprolactinoma and its Management by Bromocriptine and Cabergoline

      ea0020p172
    • Von-Hippel-Lindau disease: clinical report

      ea0020p173
    • Assessment of interferon [alpha]-2a in pharmaceutical formulations by liquid chromatography methods

      ea0020p174
    • Pregnancy and childbirth in active acromegaly patient treated with long acting somatostatin analog

      ea0020p175
    • Ectopic growth hormone-releasing hormone secretion by a neuroendocrine tumor causing acromegaly: long-term follow-up results

      ea0020p176
    • Misleading, difficult and lucky path towards a diagnosis in a medullary thyroid carcinoma case

      ea0020p177
    • Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients

      ea0020p178
    • AIP immunostaining is increased with lanreotide therapy in individuals with acromegaly and predicts changes in IGF-1 levels in female patients

      ea0020p179
    • Papillary thyroid carcinoma associated with thyroid autoimmunity: clinical and molecular characterization

      ea0020p180
    • Steroidogenic factor 1 - a valuable diagnostic and prognostic tool in patients with adrenocortical carcinoma

      ea0020p181
    • Endocrine gland-derived vascular endothelial growth factor and its receptors in adrenocortical carcinoma

      ea0020p182
    • Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue

      ea0020p183
    • Recombinant human thyrotropin in follow-up of patients with differentiated thyroid cancer

      ea0020p184
    • Estradiol influences somatostatin receptor expression and potentiates the effects of SOM230 on prostate cells

      ea0020p185
    • mTOR inhibition influences cell viability of medullary thyroid carcinoma primary cultures

      ea0020p186
    • Presence and potential pathophysiological relevance of GOAT, the ghrelin O-acylation enzyme, in human pituitary tumors

      ea0020p187
    • Efficacy of repeat surgery in patients with recurrent adrenocortical cancer

      ea0020p188
    • Tumor/liver standardized uptake values ratio [lt]1.8 on FDG-PET has a high negative predicitive value to rule-out malignancy in patients with incidentally identified non-secreting adrenal tumours

      ea0020p189
    • Serum chromogranin A assay in the biological diagnosis of pheochromocytomas and/or paragangliomas: results in 146 patients

      ea0020p190
    • Clinical features and outcome of thyroid lymphoma: the Auvergne registry

      ea0020p191
    • The comparison of serum endostatin levels between patients with metastatic and non-metastatic well differentiated thyroid cancer

      ea0020p192
    • Effectiveness and safety of combined therapy with low dose ketoconazole and cabergoline in patients with Cushing's disease partially responsive to monotherapy with cabergoline

      ea0020p193
    • Impact of surgery on clinical outcome in patients with recurrence of adrenocortical carcinoma

      ea0020p194
    • Microalbuminuria and insulin resistance in nondiabetic acromegalic patients

      ea0020p195
    • Safety of long-term combined therapy with somatostatin analogues and cabergoline (CAB) on cardiac valve in acromegaly: an echocardiography study

      ea0020p196
    • Incidence of benign and malignant neoplasms in acromegalic patients at a single institution

      ea0020p197
    • Gastric neuroendocrine tumors - new diagnostic and therapeutic approach

      ea0020p198
    • The German NET-registry: an audit on the diagnosis and therapy of neuroendocrine tumours

      ea0020p199
    • Adrenocortical carcinoma: results of surgical treatment and clinico-morphological prognostic factors

      ea0020p200
    • Parathyroid cancer

      ea0020p201
    • A National survey of neuroendocrine lung tumors

      ea0020p202
    • Efficacy and safety of 90Y-DOTATATE therapy in neuroendocrine tumours (NETs)

      ea0020p203
    • The variability of clinical presentation of multiple endocrine neoplasia syndrome type 1 as the reason of the underestimated diagnosis

      ea0020p204
    • Acromegaly in the Swedish pituitary register: background data and up to 10 years follow-up

      ea0020p205
    • Percutaneous laser ablation for palliative treatment of neuroendocrine liver metastases

      ea0020p206
    • The colonic polyps in the patients with acromegaly

      ea0020p207
    • Laboratory diagnosis of gastrinoma remains difficult

      ea0020p208
    • R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism

      ea0020p209
    • Recurrence in patients with pituitary nonfunctioning adenoma

      ea0020p210
    • Clinical feature and genetic testing in patients with multiple endocrine neoplasia syndrome type 2

      ea0020p211
    • Pancreatic neuroendocrine tumors: a national survey

      ea0020p212
    • Image-guided radioiodine therapy of HCC following AFP-promoter targeted in vivo sodium iodide symporter (NIS) gene transfer

      ea0020p213
    • The retrospective analysis of the pheochromocytoma diagnostic procedures in patients after laparoscopic adrenalectomy

      ea0020p214
    • Neuroendocrine disorders of patients with pituitary tumours

      ea0020p215
    • Insulinomas: experience of Coimbra's University Hospital, Endocrinology Department

      ea0020p216
    • The ectopic adrenocorticotropic hormone syndrome in carcinoid tumors (case report)

      ea0020p217
    • Growth hormone deficiency problems in adult patients with pituitary adenomas

      ea0020p218
    • Parathyroid surgery a paradigm shifts from inpatient to a day case surgery

      ea0020p219
    • Oktreotid-depot therapy of acromegaly with long action somatostatin analogue

      ea0020p220
    • Severe elevation of testosterone serum levels as unique finding in occult Sertoli-Leydig ovarian cell tumors

      ea0020p221
    • Treatment of active acromegaly with the somatostatin analogue lanreotide SR

      ea0020p222
    • Should we offer combination scan in all patients with parathyroid disease: a district general hospital experience

      ea0020p223
    • Lanreotide effects on glucose metabolism in evolutive acromegaly in remission during chemotherapy

      ea0020p224
  • Bone/Calcium
  • • The study of bone turnover biochemical markers in delayed puberty

      ea0020p225
    • The new biology of pituitary natriuretic peptides: novel signalling from guanylyl cyclase-B (GC-B) receptors

      ea0020p226
    • Experience with cinacalcet in primary hyperparathyroidism: results from the Swiss primary hyperparathyroidism cohort study

      ea0020p227
    • Use of Cinacalcet in patients with intractable primary hyperparathyroidism (PHPT): a UK budget impact analysis

      ea0020p228
    • Swiss primary hyperparathyroidism cohort study

      ea0020p229
    • Bone mineral density among patients with primary hyperparathyroidism with or without diabetes

      ea0020p230
    • Bone and mineral metabolism before and after kidney-pancreas transplantation in patients with type 1 diabetes

      ea0020p231
    • Clinical and molecular characterization of Spanish patients with pseudohypoparathyroidism

      ea0020p232
    • Is parathyroid function abnormal in active acromegaly?

      ea0020p233
    • The circulating concentration of adiponectin in post-menopausal women with and without osteoporosis and its association with body mass index and biochemical markers of bone metabolism

      ea0020p234
    • Glucose tolerance, insulin secretion and insulin sensitivity before and after radical treatment of primary hyperparathyroidism

      ea0020p235
    • Bone mineral density and bone turnover markers in patients with schizophrenia treated with atypical antipsychotics

      ea0020p236
    • Thin healthy women have a similar low bone mass as women with anorexia nervosa

      ea0020p237
    • Evaluation of the association between bone turnover markers and OPG/sRANK-L levels in relation with the changes of thyroid function in women with thyroid cancer

      ea0020p238
    • The results of cinacalcet therapy in patients with severe or refractory hypercalcemia due to primary hyperparathyroidism

      ea0020p239
    • The effect of short term human chorionic gonadotropin treatment on the improvement of bone mass in patients with hypogonadotropic hypogonadism

      ea0020p240
    • Role of vitamin D replacement on serum FGF-23 levels in patients with osteomalacia due to vitamin D deficiency

      ea0020p241
    • Peculiar features of bone disease in thalassemia: comparison with anorexia nervosa

      ea0020p242
    • The influence of other hormonal disturbances on the bone density and turnover in women with hyperprolactinemia of various origin

      ea0020p243
    • Effect of one year treatment with strontium ranelate on bone mineral density in women with established osteoporosis previously treated with teriparatide

      ea0020p244
    • Body composition and bone mineral density in hemodialysis patients

      ea0020p245
    • The relationship between serum TSH, free T4 and bone mineral density in pre- and postmenopausal women

      ea0020p246
    • Changes in adipokines serum levels after anticatabolic drugs in postmenopausal osteoporosis

      ea0020p247
    • Influence of age, menopause and body composition on bone mineral density in non-obese healthy Romanian subjects

      ea0020p248
    • Bone mineral density, bone turnover, serum osteoprotegerin and soluble receptor activator of nuclear factor k[beta] ligand levels in patients with differentiated thyroid cancer

      ea0020p249
    • Colecalciferol loading dose guideline for vitamin D deficient adults

      ea0020p250
    • The incidence of osteoporotic hip fracture in north west of Iran

      ea0020p251
    • Metabolic and cardiovascular risk in primary hyperparathyroidism

      ea0020p252
    • Vitamin D inadequacy in patientes who are screened for osteoporosis

      ea0020p253
    • Renal function before and after radical treatment of primary hyperparathyroidism

      ea0020p254
    • Preoperative parathyroid hormone levels are correlated with parathyroid adenoma volume, bone mineral density but not serum calcium levels

      ea0020p255
    • The change of bone mineral density in postmenopausal women treated by combined agent alendronate and alfacalcidol assessed by digital X-ray radiogrammetry

      ea0020p256
    • Primary hyperparathyroidism surgery: team report 2002-2008

      ea0020p257
    • Growth hormone secretory status and bone mineral content in postmenopausal women

      ea0020p258
    • Vitamin D status in healthy postmenopausal Iranian women

      ea0020p259
    • Could neonatal hypocalcamia have a cultural origin?

      ea0020p260
    • Bone mineral density and bone metabolism in hemodialysis patients. correlation with pth, 25ohd3 and leptin

      ea0020p261
    • Thyrotoxicosis presenting as severe life-threatening hypocalcaemia - a case report

      ea0020p262
    • Bone resorption and antiresorptive effect of bisphosphonates related to homocysteinaemia

      ea0020p263
    • A simple method for osteoporotic fracture risk assessment in women of all ages, using computed clinical and densitometrical data

      ea0020p264
    • Lipid levels before and after radical treatment of primary hyperparathyroidism

      ea0020p265
    • Vitamin D levels in young healtly premenopausal females in Slovakia

      ea0020p266
  • Clinical case reports and clinical reports
  • • Graves' disease accompanied by pheochromocytoma presenting with normal levels of catecholamines: report of a case

      ea0020p267
    • Toxic liver damage after antithyroid drugs - 2 cases. The role of 131-I in treatment

      ea0020p268
    • Lymphocytic hypophysitis case who developed empty sella to follow up

      ea0020p269
    • Liver manifestation of poorly controlled Type 1 diabetes mellitus: hepatic glycogenosis

      ea0020p270
    • Concurrent thyroid medullary, papillary carcinoma and Hashimoto thyroiditis: case report

      ea0020p271
    • The study of an immunohistochemical aggresivity marker in mammary carcinomas

      ea0020p272
    • Transient ischemic attack after oral L-thyroxine loading test: a case report

      ea0020p273
    • Hypopituitarism revealed after repetitive hyponatremia as complication of hemorrhagic fever

      ea0020p274
    • Paget's disease of sacrum: a case report

      ea0020p275
    • Possible effects of IGF-1 and IGF-3 in the development of growth failure, type 2 diabetes mellitus and severe insulin resistance in a case of Seckel syndrome

      ea0020p276
    • Polyuria as a main feature of parathyroid crisis due to parathyroid glands hyperplasia

      ea0020p277
    • Cushing syndrome caused by topical corticosteroids coexistent with pituitary incidentaloma - case report

      ea0020p278
    • Long-term follow-up of a 46XX case with congenital adrenal hyperplasia and male gender identity

      ea0020p279
    • An unusual presentation of autoimmune polyendocrine syndrome: a case report

      ea0020p280
    • Amiodarone-induced thyrotoxicosis - case report

      ea0020p281
    • Breast metastases by medullary thyroid carcinoma: case report with an update

      ea0020p282
    • Nesidioblastosis in a patient with gastrinoma

      ea0020p283
    • Common variable immune deficiency as a rare cause of osteoporosis

      ea0020p284
    • Treatment of metastatic medullary thyroid carcinoma with sorafenib

      ea0020p285
    • Gasser ganglion as pituitary tumor - case report

      ea0020p286
    • Progression of endocrine hypofunction: a case of polyglandular autoimmune syndrome type 2

      ea0020p287
    • Retroesophageal parathyroid adenoma - scintigraphic and intraoperative scintimetric localization of an ectopic parathyroid adenoma with Tc-99m tetrofosmin: a case report

      ea0020p288
    • Glucocorticoid resistance syndrome: treatment with ketoconazole, an efficient therapy solution - case report

      ea0020p289
    • Intramuscular testosterone undecanoate - the experience of 11 years

      ea0020p290
    • The R106C mutation of the V2 vasopressor receptor gene (AVPR2) causing X linked congenital nephrogenic diabetes insipidus is responsive to short term desmopressin challenge

      ea0020p291
    • Clinical analysis of 150 patients with pituitary insufficiency (20 years experience)

      ea0020p292
    • Prevalence and peculiarity of arterial hypertension treatment in acromegaly patients

      ea0020p293
    • The Ramadan: do Muslim diabetes patients adhere to their religion or to the doctor?

      ea0020p294
    • Adherence of internists and family physicians to SEMT guidelines for type 2 diabetes mellitus in Turkey

      ea0020p295
    • Subclinical hypothyroidism as a cardiovascular risk factor

      ea0020p296
    • Sustained response to interferon [alpha] in a patient with an advanced metastatic serotonin secreting endocrine tumour - case report

      ea0020p297
    • Primary hyperparathyroidism in the eastern black sea region of Turkey: a description of 101 cases

      ea0020p298
    • Nuroendocrine tumours of unusual localization

      ea0020p299
    • Successful pregnancy in a patient with Carney's complex, primary pigmented nodular adrenocortical disease and biochemical cortisol excess

      ea0020p300
    • Hungry bone syndrome following thyroidectomy for thyrotoxicosis: case report

      ea0020p301
    • Paraneoplastic Cushing's syndrome due to prostate cancer: a rare occurrence

      ea0020p302
    • Large intrathoracic goiter mimicking lung cancer

      ea0020p303
    • Double primary ovarian malignancies in a patient with bipolar disease complicating Swyer syndrome

      ea0020p304
    • Three cases with inappropriate TSH syndrome

      ea0020p305
    • Stromal luteoma of the ovary: case report

      ea0020p306
    • Coincidence of primary hyperaldosteronism with thyrotoxic nodular goiter presenting as hypokalemic periodic paralysis: complicating or mimicking one another?

      ea0020p307
    • Hypergonadotropic hypogonadism due to vanishing testis syndrome: case report

      ea0020p308
    • A case of giant-cell jaw tumour and primary hyperparathyroidism

      ea0020p309
    • [alpha]-Adrenergic blockade with doxazosin: case report

      ea0020p310
    • Graves' disease and thymic hyperplasia: case report

      ea0020p311
    • Case report: papillary thyroid carcinoma in a patient with Pendred syndrome

      ea0020p312
    • The study of an immunohistochemical aggresivity marker in mammary carcinomas

      ea0020p313
    • Schmidt's syndrome atypical case

      ea0020p314
    • Non-insulinoma pancreatogenic hypoglycemia syndrome (NIPHS): recently described disease entity: case report

      ea0020p315
    • Malignant pheochromocytoma with brain metastases and coexisting meningioma: case report

      ea0020p316
    • Postmenopausal hyperandrogenism: report of two cases

      ea0020p317
    • Prader-Willi syndrome: case report

      ea0020p318
    • Dwarfism and female extenal genitalia due to congenital partial hypopituitarism in a 46XY Seckel syndrome with microcephaly and multiple skeletal deformities

      ea0020p319
    • A case of adrenomyeloneuropathy and Addison disease

      ea0020p320
    • A primary differentiated carcinoma of ectopic mediastinal thyroid: report of two cases

      ea0020p321
    • Triple X syndrome (47, XXX) with infertility and obesity

      ea0020p322
    • Treatment of a case of metastatic thyroid cancer with sorafenib

      ea0020p323
    • Insulin autoimmune syndrome in a patient with type 2 diabetes: a case report

      ea0020p324
    • Malignant struma ovarii: a case report

      ea0020p325
    • Cushing's syndrome in a patient with bilateral adrenal masses and pituitary incidentaloma: case report

      ea0020p326
    • Cerebrospinal fluid rhinorrhoea following dopamine agonist therapy for large macroprolactinoma

      ea0020p327
  • Comparative Endocrinology
  • • Characterization of a vasoactive intestinal peptide receptor type 2 (VPAC2R) in an early jawed vertebrate, sturgeon (Acipenser schrenckii)

      ea0020p328
    • Influence of orchidectomy and testosterone replacement on adrenal cortex activity in the Saharan gerbil Gerbillus tarabuli

      ea0020p329
    • Comparative analyses between the glycoprotein-hormone receptors and the orphan leucine-rich repeat containing G-protein coupled receptor 4 (LGR4)

      ea0020p330
    • Diabetes insipidus prevalence in the Republic of Uzbekistan according to national register

      ea0020p331
    • Cortisol and biochemical changes in pregnant women

      ea0020p332
  • Diabetes and Cardiovascular
  • • Characterization of a young population of type 1 diabetics

      ea0020p333
    • How diabetic children's families inject them insulin at home

      ea0020p334
    • HLA DQB1 and HLA DQA1 genotypes prevalence in children and adolescence with new-onset diabetes type 1 in the lower Silesia region

      ea0020p335
    • Comparative molecular analysis of TRAIL ligand and receptor expression profiles in cyclophosphamide versus streptozotocin-induced diabetes in non-obese diabetic (NOD) mice

      ea0020p336
    • Association of IL-4 promoter polymorphisms in Taiwanese patients with type 2 diabetes mellitus

      ea0020p337
    • Saxagliptin added to a thiazolidinedione, metformin or a sulphonylurea improves glycaemic control in patients with inadequately controlled type 2 diabetes mellitus

      ea0020p338
    • Change of physical activity, diet habits and risk of diabetes after lifestyle intervention. Diabetes in Europe: prevention using lifestyle, physical activity, and nutritional intervention: the DePlan Project Krakow

      ea0020p339
    • Limits in using brain natriuretic peptide (BNP) as a biomarker of acute right ventricular dysfunction in pulmonary embolism

      ea0020p340
    • Determination of oxidized LDL and anti oxidized LDL antibody in patients with type 2 diabetes

      ea0020p341
    • Relationship between lipid oxidation and insulin resistance in type 2 diabetes mellitus

      ea0020p342
    • Role of soluble fas/fas ligand pathway and osteoprotegerin levels in patients with diabetic foot

      ea0020p343
    • Abstract unavailable

      ea0020p344
    • Evaluation of coronary artery disorders in diabetic patients with no or atypical cardiac symptoms

      ea0020p345
    • Impaired glucose regulation and arterial stiffness

      ea0020p346
    • Association between polymorphisms in the promoter of heme oxygenase-1 and vascular complications in type 2 diabetic patients

      ea0020p347
    • Paradoxical effects of GABA on glucose-stimulated insulin secretion from isolated islets in rat

      ea0020p348
    • Inspiratory muscle strength is correlated with carnitine levels in type 2 diabetes

      ea0020p349
    • Mildronate positively affects compensation of diabetes in streptozotocin rats and alters iNOS gene expression in rat tissues

      ea0020p350
    • Topical Atorvastatine may be beneficial in the treatment of the wounds in diabetic rats

      ea0020p351
    • Coronary heart disease risk reduction in obese patients submitted to adjustable gastric band

      ea0020p352
    • Atherogenic and anti-atherogenic risk markers in subjects with obesity and/or type 2 diabetes

      ea0020p353
    • Optimal fasting plasma glucose level for diagnosis of diabetes in a Singaporean population

      ea0020p354
    • Endogenous estrogen levels are associated with endothelial function in males independently of lipid levels

      ea0020p355
    • Glucose intolerance and risk of cardiovascular disease: results of the 7.6 year follow-up of the Tehran lipid and glucose study (TLGS)

      ea0020p356
    • Pharmacokinetics of the dipeptidyl peptidase-4 inhibitor saxagliptin in subjects with renal impairment

      ea0020p357
    • Biphasic insulin aspart 30/70 improves glycaemic control in patients with type 2 diabetes: clinical practice experience from Indian subgroup of the IMPROVE study[trade]

      ea0020p358
    • Saxagliptin either as add-on therapy to metformin or as initial combination therapy with metformin improves glycaemic control in patients with type 2 diabetes

      ea0020p359
    • Effects of estrogen therapy on cardiovascular risk factor in transsexuals

      ea0020p360
    • Carotid intima media thickness and serum osteoprotegerin and RANKL levels in diabetic and prediabetic patients

      ea0020p361
    • Klotho gene polymorphism may be a genetic risk factor for metabolic syndrome in men

      ea0020p362
    • Chemotherapy does not influence measures of glycaemic control in non-diabetic patients affected by acute leukaemia

      ea0020p363
    • Pancreatic function in [beta]-thalassemic patients

      ea0020p364
    • Characterization of type I interferon (IFN) mediated diabetes sparing activity

      ea0020p365
    • A comparison between adhesion molecules (as markers of inflammation) in identifying cardiovascular disease in postmenopausal women

      ea0020p366
    • The relationship between hemoglobin levels and endothelial functions in diabetes mellitus

      ea0020p367
    • Lack of association between polymorphisms at the adiponectin gene locus and type 2 diabetes as well as body mass index in Latvian population

      ea0020p368
    • Epicardial adipose tissue thickness and serum visfatin levels in patients with new diagnosed prediabetes and type 2 diabetes mellitus

      ea0020p369
    • The relationship between body mass index-left ventricle mass index-myocardial performance index in type 2 diabetes

      ea0020p370
    • Correlation between serum 25 hydroxy vitamin D3 and laboratory risk markers of cardiovascular diseases in type 2 diabetic patients

      ea0020p371
    • N-acetylcysteine is able to reduce the oxidation status and the endothelial activation after a high-glucose content meal in patients with type 2 diabetes mellitus

      ea0020p372
    • Hyperhomocysteinemia may be a risk factor for diabetic foot ulcer development

      ea0020p373
    • Incidence of diabetic ketoacidosis during Ramadan fasting in Benghazi, Libya

      ea0020p374
    • ECoRI polymorphism but not XBaI polymorphism of apolipoprotein B gene is associated with carotis intima media thickness in type 2 diabetic patients

      ea0020p375
    • Insulin-loaded lipid nanospheres surfaced with polysaccharides for oral delivery

      ea0020p376
    • Influence of admission plasma glucose level on short and long-term prognosis in patients with ST-Segment elevation myocardial infarction

      ea0020p377
    • The effect of glycemic control on mean platelet volume in patients with type 2 diabetes mellitus

      ea0020p378
    • Association between APOE genotype and hsCRP in Iranian population: Tehran, lipid and glucose study

      ea0020p379
    • Ca 19-9 levels in type 2 diabetes mellitus patients

      ea0020p380
    • Plasminogen activator inhibitor 1 and atherosclerosis in diabetes mellitus type 2

      ea0020p381
    • Combined treatment in childhood diabetes could influence remission period

      ea0020p382
    • Impact of age, gender, DM duration and BMI on metabolic control of T2DM patients in Jordan

      ea0020p383
    • Retinol binding protein-4 is associated with TNF-[alpha] and not insulin resistance in subjects with type 2 diabetes mellitus and coronary heart disease

      ea0020p384
    • Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran Lipid and Glucose Study

      ea0020p385
    • NovoMix30[reg] reduces hypoglycemic events with favorable weight change in poorly controlled type 2 diabetes patients: results from Indian cohort of IMPROVE Study

      ea0020p386
    • Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels in diabetic foot ulcers

      ea0020p387
    • Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus

      ea0020p388
    • Prevalence of atopic profile in patients with type 1, type 2 and LADA diabetes mellitus

      ea0020p389
    • Prevalence of cardiovascular risk polymorphisms and its association with microvascular complications in an adolescent type 1 diabetes population

      ea0020p390
    • Visfatin seems not to be related in insulin resistance

      ea0020p391
    • Anthropometric determinants of adiponectin levels in obese and non obese premenopausal women

      ea0020p392
    • Is brachial artery diameter most significant determinator of the flow-mediated dilatation?

      ea0020p393
    • General and central obesity and risk of cardiovascular disease: results of the 7.6-year follow-up study in Iranian men

      ea0020p394
    • Prevalence of undiagnosed glucose intolerance changes according to age and gender in Japanese middle aged working people

      ea0020p395
    • Diabetes and obesity associated difference in aggregation platelet capacity

      ea0020p396
    • Functional balance in diabetic neuropathy

      ea0020p397
    • Terminalia bellerica (Belliric Myrobalan) stimulates the secretion and action of insulin and inhibits starch digestion and protein glycation

      ea0020p398
    • The frequency of diabetic retinopathy and relevant factors for prediabetic subjects

      ea0020p399
    • Prognostic values of diabetic retinopathy progression for the assessment of lower limbs and heart muscle perfusion disturbances in patients with diabetes 2

      ea0020p400
    • Association between inflamation markers and metabolic parameters in type 2 diabetic patients, metabolic syndrome, impaired glucose tolerance

      ea0020p401
    • C-reactive protein level early after starting standard treatment of diabetic foot infection is associated with amputation risk

      ea0020p402
    • Use of metformin in pregnancy: a survey of Turkish physicians' attitudes

      ea0020p403
    • Predictors of amputation in diabetic foot ulcer: single centre experience in a large Turkish cohort

      ea0020p404
    • The prevalence of anemia in Iranian type 2 diabetic patients and the role of nephropathy

      ea0020p405
    • Frequency of hypogonadism in men with type 2 diabetes

      ea0020p406
    • Is testosterone therapy safe for cardiovascular system? The impact of cardiac ultrasound monitoring

      ea0020p407
    • Effects of alteration in serum testosterone levels on beta cell functions in male patients with hypogonadism and in female patients with polycystic ovary syndrome

      ea0020p408
    • Endothelium dependent hemostatic factors and subclinical inflammation in women with previous gestational diabetes mellitus

      ea0020p409
    • Metabolic syndrome and meal stimulated C-peptide levels as useful clinical markers in choosing metformin for combination therapy with sulphonylurea in type 2 diabetic subjects

      ea0020p410
    • Abstract unavailable

      ea0020p411
    • Clinical characteristics and mother-fetal results in patients with gestational diabetes

      ea0020p412
    • Quality of life in diabetes mellitus: conditional issues of treatment and coping strategies

      ea0020p413
    • Thyroid dysfunctions and serum creatine kinase levels in statins-using patients with hyperlipidemia

      ea0020p414
    • Histopatological effects of stress on the heart muscle in rats

      ea0020p415
    • Insulin casts in type 2 patients different shadows with proliferate retinopathy and those with wtent or bypass on coronary rrteries

      ea0020p416
    • Evaluation of the severity of hepatic steatosis in type 2 diabetes

      ea0020p417
    • Microalbuminuria and cardiovascular risk in diabetic patients

      ea0020p418
    • Type 2 diabetes mellitus: failure to recognize cardiovascular risk jeopardizes prevention of diabetes complications in type 2 diabetic patients in daily practice

      ea0020p419
    • Prevalence of diabetic retinopathy and its relation with other risk factors

      ea0020p420
    • Screening of the Romani population in Serbia for diabetes

      ea0020p421
    • Thyrotropin and thyroxine are associated with fasting insulin and insulin resistance in euthyroid impaired glucose tolerant subjects

      ea0020p422
    • The effects of Urtica diocia on rat pancreatic [beta] cell

      ea0020p423
    • Urtica diocia effects on glucose utilization by human muscle cells

      ea0020p424
    • Effects of oral contraceptives versus no treatment on glucose tolerance and patients' satisfaction during long time follow up in 69 hirsute patients

      ea0020p425
    • The effect of creatinine clearance on the short-term outcome of neuropathic diabetic foot ulcers

      ea0020p426
    • Mean platelet volume in women with previous gestational diabetes and its alteration during pregnancy

      ea0020p427
    • Reduction of major amputations after starting a multidisciplinary diabetic foot care team: single centre experience from Turkey

      ea0020p428
    • Prediction of developing metabolic syndrome after gestational diabetes mellitus

      ea0020p429
    • Exercise induced oxidative stress in type 2 diabetes: relation to diastolic dysfunction and hypertension

      ea0020p430
    • Serum homocysteine levels in diabetes and its relationship to nephropathy

      ea0020p431
    • Can testosterone therapy be included into diabetes treatment in men with metabolic syndrome and hypogonadism?

      ea0020p432
    • The effect of telmisartan and irbesartan treatments on insulin resistance of patients with type 2 diabetes and hypertension

      ea0020p433
    • Insulin treatment intensification in daily diabetes hospital

      ea0020p434
    • Welfare activity in day diabetes hospital in our area: our experience in 2007

      ea0020p435
  • Obesity and Metabolism
  • • Association between visceral fat and cardiovascular disease risk factors

      ea0020p436
    • Severe hypertriglyceridemia and triglyceride apheresis

      ea0020p437
    • Lower dietary acid load is related to a lower incidence of the metabolic syndrome

      ea0020p438
    • The evaluation of metabolic effects following ghrelin and salbutamol administration

      ea0020p439
    • TNFR-1 knockout protects against diet induced obesity

      ea0020p440
    • Acute inflammatory biomarker modifications as a result of a single session of submaximal exercises in obese subjects

      ea0020p441
    • Adipokines' variations due to a lower caloric intake in endocrine obese patients associating the metabolic syndrome

      ea0020p442
    • Influence of metformin on carbohydrate metabolism in young women with metabolic syndrome

      ea0020p443
    • Letrozole normalizes serum testosterone and reduces body weight in morbidly obese men with obesity-related hypogonadotropic hypogonadism

      ea0020p444
    • Effect of metformine treatment on serum paraoxonase and oxidative status in obese women

      ea0020p445
    • Serum visfatin concentration in obesity and impaired glucose tolerance - relationship with insulin resistance, blood pressure and proinflammatory factors

      ea0020p446
    • Intracerebroventricular leptin increase AKT phosphorylation stimulated by insulin in skeletal muscle: the role of adrenergic signal and JAK2 activation

      ea0020p447
    • Evidence of increased cardiovascular risk in patients with non-secreting unilateral adrenocortical adenomas

      ea0020p448
    • Metabolic syndrome highly correlates to non toxic multinodular goiter progression: iperinsulinism a way to growth

      ea0020p449
    • IGF-1 gene polymorphism in obese patients with insulin resistance

      ea0020p450
    • Familial obesity and the role of nutrition

      ea0020p451
    • Adiponectin and vascular properties in obese patients: is it a novel biomarker of early atherosclerosis?

      ea0020p452
    • A comparison of serum leptin levels and metabolic parameters included serum lipoproteins and glucose homeostasis between national wrestlers and healthy males

      ea0020p453
    • Impact of protein content of low-carbohydrate/high-fat diets upon ketosis, energy expenditure and glucose utilization in rats

      ea0020p454
    • Thyroid function tests, measures of adiposity and metabolic syndrome in apparently healthy euthyroid individuals

      ea0020p455
    • 25-Hydroxyvitamin D is associated with insulin resistance, obesity, and serum lipids in polycystic ovary syndrome

      ea0020p456
    • Chronic renal disease, hyperfiltration, metabolic syndrome and hypogonadism: is there a link?

      ea0020p457
    • Changes in serum levels of fetal antigen 1 (FA1/Pref-1/Dlk1) in extreme nutritional states

      ea0020p458
    • Influence of metformin on selected lipids and apolipoproteins concentrations in young women with metabolic syndrome

      ea0020p459
    • Correlation of leptin, total body fat mass and body fat distribution in overweight postmenopausal women

      ea0020p460
    • Diabetic patients with abnormal LFTS

      ea0020p461
    • Impact of growth hormone receptor blockade on substrate metabolism during short-term fasting in healthy subjects

      ea0020p462
    • Are hypothalamic oscillators dysfunctional with high fat feeding?

      ea0020p463
    • Glucose-dependent insulinotropic polypeptide increases glucose-uptake in muscle- and adipocyte cells in vitro

      ea0020p464
    • Glucose-dependent insulinotropic polypeptide modulates inflammatory markers in adipose tissue

      ea0020p465
    • Glucose RapidSpray[trade] as adjuvant in diet restriction programmes

      ea0020p466
    • Plasma monocyte chemoattractant protein-1 and macrophage inflammatory protein-1[alpha] are increased in patients with polycystic ovary syndrome and associated with adiposity, but unaffected by pioglitazone treatment

      ea0020p467
    • Elevated prolactin serum level in erectile dysfunction cases can be predict by metabolic syndrome

      ea0020p468
    • Sexual dysfunction in women with obesity

      ea0020p469
    • Effects of green tea consumption on blood pressure, total cholesterol, body weight and fat in healthy volunteers

      ea0020p470
    • Subcutaneous adipose tissue topography and metabolic disturbances in polycystic ovary syndrome

      ea0020p471
    • Melanocortin-4-receptor gene variants: hotspot or identical by descent?

      ea0020p472
    • Association between platelet count and metabolic risk factors in over weight and obese women

      ea0020p473
    • The evaluation of the oxidative stress in obese adolescent girls with full or partial metabolic syndrome

      ea0020p474
    • The role of family and parental factors in childhood obesity

      ea0020p475
    • Relationship of serum gamma-glutamyltransferase and adiposity measures with C-reactive protein in severe obese women

      ea0020p476
    • A retrospective analysis of the relationship of thyroid function with obesity in a single center obesity outpatient policlinic

      ea0020p477
    • Relationship between prehypertension and metabolic risk markers in over weight and obese women

      ea0020p478
    • Short term elevation of estradiol concentrations does not affect hepatic VLDL-TG production

      ea0020p479
    • Serum adiponectin levels and polymorphism of CB1 endocannabinoid receptor (A3813G, A4895G, G1422A) in postmenopausal women

      ea0020p480
    • Relationships of TNF[alpha] system with glucose and lipid oxidation in subjects with different degree of insulin sensitivity

      ea0020p481
    • Variation of daytime melatonin levels

      ea0020p482
    • Aromatase expression in peripheral blood leukocytes from adult and elderly female and male subjects

      ea0020p483
    • Non-diabetic metabolic syndrome and obesity do not affect serum paraoxonase-1, HDL-paraoxonase and arylestherase activities but affects oxidative stress and inflamation

      ea0020p484
    • Carotid IMT values are related to insulin resistance and visceral disposition of adiposity in obese patients

      ea0020p485
    • The effect of weight loss on serum mannose binding lectin levels

      ea0020p486
    • Insulin resistance and anemia markers

      ea0020p487
    • Vasomotor dysfunction and alterations of adipokines in metabolic syndrome patients with insulin resistance

      ea0020p488
    • Effect of pharmaceutical intervention on serum levels of advanced glycated end products in women with polycystic ovary syndrome

      ea0020p489
    • Insulin-resistance and abnormal glycaemia characterize the metabolic syndrome of polycystic ovary syndrome but not of matched controls

      ea0020p490
    • Regulation of novel metabolic regulator fibroblast growth factor-21 by body adiposity and hypercortisolemia: studies in patients with obesity and Cushing's syndrome

      ea0020p491
    • The influence of weight lose on immune system

      ea0020p492
    • Plasma levels of uric acid in the patients with fatty liver

      ea0020p493
    • The atherogenic index in the fatty liver

      ea0020p494
    • Energy and nutrients intake among overweight/obese school children in Tehran

      ea0020p495
    • Influence of finasteride treatment on metabolic profile of men with androgenetic alopecia

      ea0020p496
    • Prevalence of hypo- and hypermagnesemia in an urban population

      ea0020p497
    • The effect of [alpha]-lipoic acid on myostatin and myosin heavy chain isoform profile of skeletal muscle of OLETF rats

      ea0020p498
    • Comparing the activity of orlistat and sibutramine on obesity treatment

      ea0020p499
    • Normal metabolic flexibility despite insulin resistance in lean and obese women with polycystic ovary syndrome

      ea0020p500
    • Lipid levels in anorexia nervosa patients

      ea0020p501
    • Prevalence of the metabolic syndrome in men with late-diagnosed Klinefelter syndrome

      ea0020p502
    • Metabolically healthy but obese individuals

      ea0020p503
    • Effects of stress on kidney: a histochemical study on rat model

      ea0020p504
    • Anthropometric parameters and non alcoholic hepatic steatosis in type 2 diabetes

      ea0020p505
  • Endocrine Disruptors
  • • Reproductive and haematological toxicity of Nurelle D 220 EC in male rats

      ea0020p506
    • The association between organochlorine compounds, iodine intake and thyroid hormones during pregnancy

      ea0020p507
    • Histopathologic changes of exocrine and endocrine pancreas in stress-exposed female rats

      ea0020p508
    • The effect of feeding of aerial part of Vaccinium myrtillus on blood glucose and lipids of diabetic rats

      ea0020p509
    • Effect of silymarin on nerve conduction velocity, hyperalgesia and oxidative stress in experimental diabetic neuropathy

      ea0020p510
    • Testosterone serum level in haemodialysed male patients positively correlates with adequacy of dialysis

      ea0020p511
    • Effects of permethrin on sexual behaviour and plasma concentrations of pituitary-gonadal hormones in adult male NMRI mice

      ea0020p512
    • Hyperprolactinaemia in men

      ea0020p513
    • Association of CTLA4+49 A/G polymorphism with type 1 diabetes in Tunisian population

      ea0020p514
    • Why does Klinefelter syndrome often remain undiagnosed?

      ea0020p515
  • Paediatric Endocrinology
  • • Short stature in pediatric Cushing's syndrome: effectiveness of hypercortisolism cure

      ea0020p516
    • Serum nitric oxide metabolites and clustering of metabolic syndrome components in paediatrics: an exploratory factor analysis

      ea0020p517
    • A common deletion in the uridine diphosphate glucuronyltransferase (UGT) 2B17 gene is a strong determinant of androgen excretion in healthy pubertal boys

      ea0020p518
    • Sex hormone-binding globulin levels predict insulin sensitivity, disposition index and cardiovascular risk during puberty

      ea0020p519
    • Mild hypothyroidism in children with congenital heart malformations

      ea0020p520
    • Increased intra-erythrocyte magnesium is associated with gamma-glutamyl transferase in obese children

      ea0020p521
    • Iodine levels and thyroid hormones in healthy pregnant women and birth weight of their offspring

      ea0020p522
    • Development of multiple pituitary hormone deficiency (MPHD) in pediatric patients originally diagnosed with isolated GH deficiency (IsGHD)

      ea0020p523
    • Clinical and genetic features of type 1 diabetes mellitus and autoimmune thyroiditis combination in Belarusian Children

      ea0020p524
    • LEOPARD syndrome and pilocytic astrocytoma: a random association?

      ea0020p525
    • Genetic characterization of children with isolated growth hormone deficiency in Turkish population

      ea0020p526
    • Growth hormone receptor (GHR) mutations in Turkish children with Laron syndrome

      ea0020p527
    • Childhood obesity and bone age

      ea0020p528
    • The effect of one year of therapy with rhgh on growth velocity in patients with growth hormone deficiency (GHD)

      ea0020p529
    • The goiter etiology in children of the south west of Romania

      ea0020p530
    • Influence of the exon 3: deleted polymorphism of the GH receptor on glucose and lipid metabolism in GH treated subjects with GH deficiency: results of a preliminary study

      ea0020p531
    • 'Hidden' congenital adrenal hyperplasia: case report

      ea0020p532
    • Prevalence of autoimmune thyroiditis in children with diabetes mellitus

      ea0020p533
  • Growth and Developmental Endocrinology
  • • Characterization of growth hormone (GH) mutants R77C and D112G found in patients with retarded growth

      ea0020p534
    • The effect of fetal hypothyroidism on carbohydrate metabolism during adulthood in rats

      ea0020p535
    • Development of specific monoclonal antibodies and highly sensitive immunoassays for 20 kDa and 22 kDa human growth hormone (hGH)

      ea0020p536
    • The effect of gestational hypothyroidism on insulin secretion from isolated islets of adult offspring in male rats

      ea0020p537
    • Short stature in betathalassemia major: a multifactorial condition

      ea0020p538
    • Histopathologic changes in pregnant rat pancreas

      ea0020p539
  • Growth Factors
  • • IGFBP3 and IGFBP2 negatively and positively modulate IGFs autocrine effect in lung cancer cell lines

      ea0020p540
    • Exogenous growth hormone administration effects organ weights but does not markedly change serum IGF-I levels in common mice

      ea0020p541
    • Immunohistochemical analysis of VEGF and CD34 in adrenal cortical tumors

      ea0020p542
    • Effects of intraperitoneal gibberelic acid (GA3) on IGF-1 and growth hormone (GH) in the rats

      ea0020p543
  • Neuroendocrinology, Pituitary and Behaviour
  • • The effects of selective serotononin reuptake inhibitors on the thyroid axis in perimenopausal depression

      ea0020p544
    • Pre-treatment IGF-I concentrations predict radiographic osteoarthritis in acromegalic patients with long-term cured disease

      ea0020p545
    • The prevalence of diabetes mellitus in 9776 adult patients with childhood- and adult-onset growth hormone (GH) deficiency before GH replacement: a KIMS analysis

      ea0020p546
    • Effects of 3 years growth hormone (GH) replacement in adult-onset growth hormone deficiency (GHD) due to controlled Cushing's disease (CD)

      ea0020p547
    • The cost-effectiveness of growth hormone (GH) treatment (Genotropin[reg]) in adult patients with growth hormone deficiency (GHD)

      ea0020p548
    • High TSH levels in healthy pregnant women are related to a decrease in motor development of their children at 14 months of age

      ea0020p549
    • Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly

      ea0020p550
    • The low-dose ACTH stimulation test in the assessment of outcome of pituitary surgery for Cushing's disease

      ea0020p551
    • The D3 GH receptor polymorphism is associated with osteoarthritis, especially of the hip, in patients with long-term cured acromegaly

      ea0020p552
    • Ghrelin as new provocative test for the diagnosis of GH deficiency in adults

      ea0020p553
    • Screening for neuroendocrine dysfunction in patients after spontaneous subarachnoid hemorrhage

      ea0020p554
    • Characterisation of PARS, a novel putative pituitary regulator of hormone secretion

      ea0020p555
    • Combined treatment for acromegaly with long-acting somatostatin analogues and pegvisomant: long-term safety up to 4.5 years of follow-up in 86 patients

      ea0020p556
    • Impact of long-term growth hormone (GH) substitution on lipid metabolism and bone mineralisation (BMD) in pituitary insufficient patients with growth hormone deficiency (GHD)

      ea0020p557
    • Effect of intracerebroventricular infusion of bombesin in glucose dependent insulinotropic peptide on conscious dogs

      ea0020p558
    • Plurihormonal cells are more frequent in early embryofetal stages of the human pituitary

      ea0020p559
    • Ovariectomy causes hippocampal neuronal loss and cognitive dysfunction and restored by Ginkgo biloba extract EGb761 in rats

      ea0020p560
    • Glucose tolerance and somatostatin analogues treatment in acromegaly: a 12 month open, prospective study

      ea0020p561
    • Heart rate variability of young men with hypogonadotropic hypogonadism

      ea0020p562
    • The impact of infertility on the relationship of people with a Pituitary condition

      ea0020p563
    • Carotid intima media thickness and other cardiovascular risk factors in acromegalic patients

      ea0020p564
    • Expression and regulation of HIF-1[alpha] and RSUME in murine and human pituitary tumor cells

      ea0020p565
    • MicroRNA expression in human sporadic pituitary adenomas

      ea0020p566
    • Progesterone up-regulates transthyretin levels in primary cultures of choroid plexus epithelial cells

      ea0020p567
    • Long-term follow-up of female patients with prolactinoma: is there a place for surgery in the therapy of prolactinoma?

      ea0020p568
    • Clinical presentation, long-term follow-up and bone morbidity of male patients with prolactinoma

      ea0020p569
    • Effects of somatostatin analogs on glucose homeostasis: a meta-analysis of acromegaly studies

      ea0020p570
    • Macroprolactinemia in patients with pituitary adenomas

      ea0020p571
    • Primary medical treatment of large and giant prolactinomas

      ea0020p572
    • Transport activities and plasma membrane localization of MCT8 mutant proteins identified in patients with severe psychomotor retardation depend on cell type. Implications for the interpretation of clinical phenotypes

      ea0020p573
    • Is it possible to avoid hypopituitarism after the irradiation of pituitary adenomas by the Leksell gamma-knife?

      ea0020p574
    • Effect of prolonged treatment with potassium canrenoate, a MR antagonist, on basal and stimulated hypothalamus--pituitary--adrenal (HPA) axis in humans

      ea0020p575
    • Initial and long-term outcome of surgery in acromegaly: a ten-year, single centre study in 115 patients

      ea0020p576
    • Two repeated restraint stress paradigms differing in duration and frequency result in similar levels of HPA habituation, but differences in neuropeptide expression and testosterone levels

      ea0020p577
    • Association of Interleukin-6 with hot flashes in perimenopausal women

      ea0020p578
    • Empty sella and primary autoimmune hypothyroidism

      ea0020p579
    • Human corticotropin releasing hormone (hCRH) test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis

      ea0020p580
    • Hemostatic and fibrinolytic changes in patients with Cushing's disease

      ea0020p581
    • Immunoassay determination of macroprolactin in hyperprolactinemic patients: an interassay comparative study

      ea0020p582
    • Adiponectin and visfatin: a link with bone mineral density in acromegaly

      ea0020p583
    • Feedback inhibition of prednisolone on vasopressin (AVP) secretion but preserved renal water reabsorption after thirsting point to an AVP independent antidiuretic action

      ea0020p584
    • Genetic alterations of phosphodiesterase 11A (PDE11A) in acromegalic patients

      ea0020p585
    • Neuroendocrine effects of stress in hostile heavy social drinkers: exploring the involvement of serotonin using dietary tryptophan manipulation

      ea0020p586
    • GH response to oral glucose tolerance test: a comparison between patients with pituitary disease and healthy subjects

      ea0020p587
    • Quality of life (QoL) in patients with Cushing's syndrome in a Spanish population: new experience with the CushingQoL questionnaire

      ea0020p588
    • Five year experience with GH replacement therapy on tumor occurrence or recurrence: one center study

      ea0020p589
    • Androgen deficiency is additional risk factor for bone health in growth hormone deficient men

      ea0020p590
    • The correlations of ghrelin concentrations and lipid profile in patients with acromegaly

      ea0020p591
    • Glucose metabolism alterations in acromegaly

      ea0020p592
    • ACTH-secreting bronchial carcinoid: a role of somatostatin analogues in diagnosis and treatment

      ea0020p593
    • Dose interval comparison of Lanreotide Autogel 120 mg in acromegalic patients previously treated with Octreotide LAR

      ea0020p594
    • Growth hormone replacement therapy in adult onset growth hormone deficiency induces favorable long-term effects on quality of life, bone, body composition and lipids: a 55 month prospective study

      ea0020p595
    • GH deficiency in HIV-infected patients with lipodystrophy: preliminary data on the effects of r-hGH treatment on body composition

      ea0020p596
    • Can the pineal gland modulate the effects of kisspeptin on the puberty onset in female rats?

      ea0020p597
    • Central diabetes insipidus after transsphenoidal treatment for tumors of the sellar region: prognostic factors for transient course of the disease

      ea0020p598
    • Food deprivation affects arcuate neurons in the hypothalamus of young rats

      ea0020p599
    • Plasma levels of neuropeptide Y and peptide YY in patients affected by Anorexia nervosa and severe obesity

      ea0020p600
    • From the horse's mouth: recommendations to improve care for pituitary patients. Results from a survey on pituitary patients' satisfaction with information and support from healthcare professionals

      ea0020p601
    • Pituitary insufficiency with a HESX1 mutation: a new case

      ea0020p602
    • Prevalence of colonic polyps in acromegalic patients and relationship between glycemic status

      ea0020p603
    • Results of acromegaly patients treated with surgery and/or somatostatin analog and/or radiotherapy in a University Hospital in Turkey

      ea0020p604
    • Hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome

      ea0020p605
    • Normalization of ACTH and cortisol responses to ghrelin in patients cured from Cushing's disease

      ea0020p606
    • The role of androgen receptors in the medial amygdala on biosynthesis and stress-induced cellular activation of the paraventricular nucleus of the hypothalamus

      ea0020p607
    • GH resistance in a group of chronic fatigue syndrome patients

      ea0020p608
    • Presenting pattern and etiologies of hyperprolactinemia in north west of Iran

      ea0020p609
    • An exceptional image: multiple sclerosis and hypogonadism

      ea0020p610
    • Health related quality of life in patients with diabetes mellitus type 2 in comparison to patients with other endocrine diseases

      ea0020p611
    • Pregnancy occurs rarely in acromegalic patients: although octreotide therapy in pregnancy seems to be feasible and safe, enough information regarding the use of OCT in pregnancy is not available yet

      ea0020p612
    • Observational outcome of Korean acromegalics based on OASIS registry

      ea0020p613
    • Plasma thrombin-activatable fibrinolysis inhibitor antigen levels in acromegalic patients

      ea0020p614
    • Prolactinoma in east-black sea Turkey: a description of 51 cases

      ea0020p615
    • Acromegaly in the eastern black sea region of Turkey: a description of 42 cases

      ea0020p616
    • Long-term treatment of a misdiagnosed TSH-oma patient with antidepressants and antithyroid drugs

      ea0020p617
  • Reproduction
  • • The effect of nutritional supplement (Menopace[reg]) on the frequency of hot flushes, night sweats, mood and quality of life in post-menopausal women: a placebo-controlled double blind study

      ea0020p618
    • Clinical characteristics of Algerian PCOS women

      ea0020p619
    • Influence of hyperprolactinemia on prolactin receptor manifestation and hepatic bilirubin excretory activity under condition of female rat obstructive cholestasis

      ea0020p620
    • The prevalence of subclinical late - onset hypogonadism in men with diabetes type 2

      ea0020p621
    • Adiponectin increases insulin-like growth factor I-induced progesterone and estradiol secretion in human granulosa cells

      ea0020p622
    • Effects of thyroid hormones on ovary granulosa cells: regulation of proliferation, survival and function

      ea0020p623
    • Successive degradation of StAR by soluble and membrane-bound mitochondrial proteases: plausible mechanism protecting steroidogenic mitochondria under 'protein stress'

      ea0020p624
    • AdipoR1 and AdipoR2 Inactivation by RNA interference in the KGN human granulosa cell line: potential involvement of AdipoR1 in cell survival and AdipoR2 in steroidogenesis

      ea0020p625
    • Progesterone suppression of the male hypothalamo-pituitary gonadal axis is partially reversed by the progesterone antagonist mifepristone

      ea0020p626
    • Isradipine inihibits oxytocin-induced contractions of isolated myometrium from late pregnant rat

      ea0020p627
    • Obesity resulting from Gs-alpha mutations in the maternal (but not paternal) allele is a consequence of Gs-alpha imprinting in the central nervous system

      ea0020p628
    • Prolonged qt (corrected) dispersion in women with polycystic ovary syndrome

      ea0020p629
    • Free thiols in human spermatozoa: correlation with Na+/K+-ATPase, Ca2+-ATPase activities and sperm motility

      ea0020p630
    • Influence of polycystic ovary syndrome and obesity on vascular parameters (common carotid artery intima-media thickness - CCA-IMT, common carotid artery compliance - CP-CCA and endothelium function of the brachial artery - FMD) related to the process of atherosclerosis

      ea0020p631
    • Impact of the type of diabetes in pregnancy upon pregnancy outcome

      ea0020p632
    • Advanced glycosylated end products are associated with anovulatory markers in women with polycystic ovary syndrome

      ea0020p633
    • A systematic review and a meta-analysis on adiponectin levels in women with polycystic ovary syndrome

      ea0020p634
    • Gonadotropin releasing hormone-induced histone modifications and gonadotropin gene expression

      ea0020p635
    • Candidate gene analyses in Caucasian patients with primary ovarian insufficiency

      ea0020p636
    • Penile size and testicular volume in healthy Lithuanian newborns

      ea0020p637
    • The effects of stress on the histological structure of rat testis

      ea0020p638
    • Effect of lamotrigine and carbamazepine on selected reproductive hormones, lipid profiles and ovarian histology in female rats

      ea0020p639
    • Effects of electromagnetic fields of cellular phone on testosterone and progesterone hormones rate in Syrian Hamsters (Mesocricetus auratus)

      ea0020p640
    • Is there a need for withdrawal test with oral micronized natural progesterone in the evaluation of women with polycystic ovary syndrome?

      ea0020p641
    • Gonadal function in male mountain bikers

      ea0020p642
    • The effects of metformin therapy in women with idiopathic hirsutism

      ea0020p643
    • Impact of gestational impaired glucose tolerance test on pregnancy outcome

      ea0020p644
    • A monocentric study of 360 consecutive patients presenting with premature ovarian failure

      ea0020p645
    • Effect of an oral contraceptive on emotional distress of women with polycystic ovary syndrome: a prospective study

      ea0020p646
    • Spermatogenesis in men with late-onset hypogonadism, receiving testosterone-gel

      ea0020p647
    • Prostatic secreted proteins in mice and rats: Identification using mass spectrometric analysis and the hormone dependent expression

      ea0020p648
    • Erectile dysfunction among HIV-infected men is associated with protease inhibitor containing HAART

      ea0020p649
    • Abstract unavailable

      ea0020p650
    • Screening of maternal thyreopathies in Slovakia: is it worth it?

      ea0020p651
    • Temporal dexamethasone treatment: responses in uterine proliferative mechanisms induced by neurogenic stimulation

      ea0020p652
    • Hyperprolactinemia in polycystIc ovary syndrome

      ea0020p653
    • Serum androgen levels correlate well with metabolic parameters in polycystic ovary syndrome

      ea0020p654
    • Abstract

      ea0020p655
    • Use of estradiol benzoate in presynch method in lactating dairy cows

      ea0020p656
    • Prolonged treatment with N-acetylcysteine and L-arginine restores gonadal function in patients with PCO syndrome

      ea0020p657
    • Does the point of time of menstrual irregularities appearance influence clinical, metabolic, hormonal profile and ultrasound findings in PCOS women?

      ea0020p658
    • Adiponectin levels and its relation to indices of insulin resistance in women with PCOS

      ea0020p659
    • Preterm menopause and some of its related factors among over 40 years old women

      ea0020p660
    • Does idiopathic hyperandrogenemia exist?

      ea0020p661
    • Ovulation induction and multicentric follow-up of 21 pregnancies in 14 patients

      ea0020p662
    • The effects of subclinical hypothyroidism treatment in PCOS women with metabolic syndrome

      ea0020p663
    • Total ghrelin levels in obese and non-obese patients with polycystic ovary syndrome

      ea0020p664
    • Our experience in treatment of infertility in patients with Klinefelter syndrome (mosaic karyotype 46,XY/47,XXY)

      ea0020p665
    • Periodontal disease in polycystic ovary syndrome

      ea0020p666
    • Selected cytokines are associated with markers of insulin resistance in polycystic ovary syndrome

      ea0020p667
  • Steroid Receptors
  • • Increased fat mass in androgen receptor knockout mice is caused by decreased physical activity with no change in food consumption

      ea0020p668
    • Androgen receptor gene CAG(n) repeat polymorphism and coronary artery disease (CAD) in women

      ea0020p669
    • Association study of the estrogen receptor alfa gene polymorphism and age-dependent endocrine changes in a Romanian population

      ea0020p670
    • Effect of the androgen receptor gene GGN repeat polymorphism on serum testosterone levels in healthy men

      ea0020p671
    • ACTH-independent Cushing's syndrome in pregnancy with normal adrenal glands: ectopic receptors to chorionic gonadotrophin hormone (HCG)?

      ea0020p672
    • Non-classical rapid effects of glucocorticoids on the beta cell function in response to glucose in healthy men

      ea0020p673
    • Calculated free testosterone as 'gold standard' for diagnosis of hypogonadism among HIV-infected men

      ea0020p674
    • Rat female derived adipose tissues respond to estrogens and vitamin D metabolites of in vivo

      ea0020p675
    • Androgen insensitivity in the genesis of the mild penile size abnormalities in young belarussian men

      ea0020p676
    • Effects of seocalcitol, TTNPB, phytol or their combinations on MNU-induced carcinogenesis of mammary gland and nuclear receptors expression in mammary tumours of female Sprague-Dawley rats

      ea0020p677
  • Signal Transduction
  • • The MAPKinases ERK1/2 take centre stage in somatotroph physiopathology

      ea0020p678
    • Retinol-binding protein 4 activates TGB-[beta]1 expression and apoptosis via phosphorylation of JNK and MAPK in HEK cells

      ea0020p679
    • Identification of septin 3 as new protein-protein interaction partner of TrkB

      ea0020p680
    • A newly identified loss-of-function mutation in helix 5 reveals new insights into signalling mechanisms of the thyrotropin receptor

      ea0020p681
    • Abstract unavailable

      ea0020p682
    • Abstract unavailable

      ea0020p683
    • Nuclear orphan receptor Nur77 is a mediator of p53-dependent apoptotic response

      ea0020p684
    • On the importance of the selenium status for the inflammatory response

      ea0020p685
    • Orexins activates protein kinase C-mediated Ca2+ signaling in cultured rat dorsal root ganglion neurons

      ea0020p686
    • High susceptibility haplotypes of the TSHR gene in Graves-Basedow disease

      ea0020p687
    • The effect of circulating estradiol concentrations on gonadotropin secretion in young and old castrated men

      ea0020p688